<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3ABV_Antibiotics%2Fen</id>
	<title>Template:BV Antibiotics/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3ABV_Antibiotics%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:BV_Antibiotics/en&amp;action=history"/>
	<updated>2026-04-20T00:31:12Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:BV_Antibiotics/en&amp;diff=384274&amp;oldid=prev</id>
		<title>FuzzyBot: Updating to match new version of source page</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:BV_Antibiotics/en&amp;diff=384274&amp;oldid=prev"/>
		<updated>2026-01-26T01:41:34Z</updated>

		<summary type="html">&lt;p&gt;Updating to match new version of source page&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;&amp;lt;languages/&amp;gt;&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====First Line Therapy&amp;lt;ref name=&amp;quot;CDC Sexually Transmitted Infections Treatment Guidelines, 2021&amp;quot;&amp;gt;CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]&amp;lt;/ref&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500 mg PO Twice Daily for 7 days OR&lt;br /&gt;
*[[Special:MyLanguage/Metronidazole|Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR&lt;br /&gt;
*[[Special:MyLanguage/Clindamycin|Clindamycin]] cream 2%, one full applicator (5 g) intravaginally Nightly for 7 days&lt;br /&gt;
Metronidazole does not cause a disulfiram-like reaction with alcohol.&amp;lt;ref name=&amp;quot;Is combining metronidazole and alcohol really hazardous?&amp;quot;&amp;gt;Is combining metronidazole and alcohol really hazardous?[http://www.ncbi.nlm.nih.gov/pubmed/25223673]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Alternative Regimin====&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Clindamycin|Clindamycin]] 300 mg PO BID for 7 days OR&lt;br /&gt;
*[[Special:MyLanguage/Clindamycin|Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)&lt;br /&gt;
Other regimens have been studied and have varying efficacy compared to placebo but due to cost and availability do not represent alternatives outside of absolute contraindications to preferred regimens.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Pregnant====&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500mg PO Twice a day x 7 days&amp;lt;ref name=&amp;quot;CDC Sexually Transmitted Infections Treatment Guidelines, 2021&amp;quot;&amp;gt;CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 250mg PO Three times a day has also been studied&amp;lt;ref name=&amp;quot;Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis&amp;quot;&amp;gt;Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study&amp;quot;&amp;gt;Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]&amp;lt;/ref&amp;gt;&lt;br /&gt;
* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women&amp;lt;ref name=&amp;quot;CDC Sexually Transmitted Infections Treatment Guidelines, 2021&amp;quot;&amp;gt;CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Prophylaxis ([[Special:MyLanguage/Sexual Assault|Sexual Assault]])====&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500mg PO Twice a day x 7 days&amp;lt;ref name=&amp;quot;Sexual Assault and Abuse and STIs – Adolescents and Adults&amp;quot;&amp;gt;Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]&amp;lt;/ref&amp;gt;&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>